Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

RAPS

Published November 16, 2026 · Updated November 17, 2026

Recon: FDA rejects ivonescimab for lung cancer indication; J&J to buy eye disease biotech ... - RAPS

Read the full story at RAPS

HHS funnels funding and research toward ibogaine and other psychedelics , with Mark Cuban's help (Endpoints) ... Biologics/biosimilars/vaccines Europe.

Surfaced by this Google Alert

  • Psychedelics europe